Gene Editing Service Smart Strategies of the Research and Development Process
Gene Editing service options are available from several specialized providers. Choosing to outsource this application may not only save time and effort, but can also provide benefits from technical expertise and facilities dedicated to customized gene and genome editing. Such services can offer researchers the advantages of CRISPR-Cas9-based editing methods and comprehensive workflows--from experimental design, to cell line development and validation. In deciding on a service, among the factors to consider include the desired method of gene editing, such as CRISPR or TALEN
Genome editing (also called gene editing) is a group of technologies that give scientists the ability to change an organism's DNA. These technologies allow genetic material to be added, removed, or altered at particular locations in the genome.
Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, are some of the factors propelling the growth of the genome editing market. However, high cost of genomic equipment may impede the market growth.
Get PDF Brochure Here http://bit.ly/3bQ3OxT
For instance, the first-ever human trials of CRISPR focused on treating a various cancers in China and the first human trials for CRISPR tech in the US set to focus on disease such as sickle cell. Progress in availability of computational tools and wet-lab genome editing (GE) technologies have greatly expanded the capability for the complex requirements of system-level investigation of microbes. Microbial gene editing tools such as targetrons, zinc finger nucleases (ZFNs), meganucleases (MNs), (CRISPR)-associated nuclease Cas9 and transcription activator-like effector nucleases (TALENs), and, creates huge opportunity for the gene editing in the forecast period. All these tools can achieve accurate and precise genetic modifications by inducing targeted DNA double strand breaks.
There are approximately 2,700 clinical trials using gene therapies under way or approved around the world. Furthermore increasing number of skilled labors will create opportunity for development of new tools in future which will bring significant growth in the revenue of microbial gene editing services market in the forecast period.
Key service provider present in the global microbial gene editing services market are GenScript USA, Horizon Discovery Group plc., Integrated DNA Technologies Inc., Lonza Group Ltd, Merck & Co., New England Biolabs Inc., Origene Technologies Inc., Sangamo Biosciences, Thermo Fisher Scientific, Transposagen Biopharmaceuticals.
Source: The Insight Partners